In collaboration with the Medical University of South Carolina, Clemson University announced on Thursday, July 16, it will have a drive-thru mobile testing site for employees who will be required to come to the campus before Aug. 1.
Testing will be available Monday, July 20, until Wednesday, July 22, from 8 a.m. to 1 p.m. at the NewSpring Church parking lot at 13200 Clemson Blvd. in Seneca, according to a statement by the university.
Those tested will be contacted in five to seven days or sooner with their test results.
The testing on these days will only be for faculty and staff who have already been working on campus as well as those who will be returning to campus in the next two weeks.
COVID-19 testing for these employees will be free; however, employees must bring proof of insurance with them to the testing site.
Related: Clemson reveals three-phase plan to allow in-person classes for fall 2020
Employees who have already been working on campus can go back to their workplaces. Employees who have yet to return to campus must provide a negative test result before returning.
“Population testing provides the university with an overview of the initial scale and scope of the virus in our population, which will allow for us to both minimize the initial incidence as well as provide vital information to guide our population health surveillance practices throughout the semester,” said David Sudduth, director of Healthy Me – Healthy SC, a collaboration between Clemson and MUSC.
Clemson already announced that those who work or study at the university must have proof of a negative COVID-19 test five days prior to returning to their facility for the upcoming semester.
“By testing our returning population, we are giving ourselves a better opportunity to continue the semester by not overwhelming our systems,” said Tony Wagner, Clemson’s executive vice president for finance and operations. “We also recognize Clemson has an obligation not only to our students, faculty and staff, but to the larger community and its impact on those with underlying issues who may be at higher risk.”
